4: Statement of changes in beneficial ownership of securities-Director Barry Richard
Apr 25 09:20 ET
4: Statement of changes in beneficial ownership of securities-Officer Kupiec James William
Apr 22 09:20 ET
4: Statement of changes in beneficial ownership of securities-Officer Schoen Eric
Apr 17 16:26 ET
Cassava Sciences | 8-K: Redemption Date Announced for Warrants
Apr 15 16:05 ET
Cassava Sciences | DEF 14A: Definitive information statements
Mar 26 08:14 ET
Cassava Sciences | ARS: Annual Report to Security Holders
Mar 22 09:02 ET
Cassava Sciences | 10-K: Annual report
Feb 28 16:04 ET
Cassava Sciences | 8-K: Cassava Sciences Reports Full-year 2023 Financial Results and Corporate Updates
Feb 28 09:27 ET
Cassava Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.51%)
Feb 13 18:14 ET
Cassava Sciences | 8-K: No Decline in Cognition Scores in Patients with Mild Alzheimer's Disease Who Received Simufilam Continuously For 24 Months
Feb 7 09:26 ET
Cassava Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Remi Barbier(5.7%)
Feb 1 16:03 ET
Cassava Sciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(7.2%)
Jan 26 16:29 ET
Cassava Sciences | CERT: Others
Jan 3 00:00 ET
Cassava Sciences | 424B2: Prospectus
Jan 3 00:00 ET
Cassava Sciences | 8-A12B: Registration of a class of securities on a national securities exchange
Jan 3 00:00 ET
Cassava Sciences | 8-K: Entry into Material Definitive Agreements
Jan 3 00:00 ET
Cassava Sciences | 8-A12G: Others
Jan 2 00:00 ET
Cassava Sciences | 8-K: Current report
Dec 12, 2023 09:19 ET
Cassava Sciences | 8-K: Current report
Dec 11, 2023 16:18 ET
Cassava Sciences | 4: Statement of changes in beneficial ownership of securities-Director Nicaise Claude
Dec 8, 2023 17:06 ET
No Data
No Data